Evidence map›Paper›PMID 33064727›Full record

ArticlePLoS genetics2020

The Ccr4-Not complex regulates TORC1 signaling and mitochondrial metabolism by promoting vacuole V-ATPase activity.

Hongfeng Chen, P Winston Miller, Daniel L Johnson, R Nicholas Laribee

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hongfeng ChenDepartment of Pathology and Laboratory Medicine, College of Medicine and the Center for Cancer Research, University of Tennessee Health Science Center, Memphis, TN, United States of America.ORCID 0000-0002-0705-0946
P Winston MillerMolecular Bioinformatics Core and the University of Tennessee Health Science Center Office of Research, University of Tennessee Health Science Center, Memphis, TN, United States of America.ORCID 0000-0003-1729-321X
Daniel L JohnsonMolecular Bioinformatics Core and the University of Tennessee Health Science Center Office of Research, University of Tennessee Health Science Center, Memphis, TN, United States of America.ORCID 0000-0003-1600-6768
R Nicholas LaribeeDepartment of Pathology and Laboratory Medicine, College of Medicine and the Center for Cancer Research, University of Tennessee Health Science Center, Memphis, TN, United States of America.ORCID 0000-0003-4519-4470
University of Tennessee Health Science Center · US

Funding

Mechanisms of transcription coregulator usage by the target of rapamycin pathwayR01GM107040 · NIGMS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI LARIBEE, RONALD · 2013 to 2017
$1.4M
Endolysosomal-nuclear communication mediated through V-ATPase and NHE9 dependent epigenetic signalingR21CA233028 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI LARIBEE, RONALD · 2019 to 2020
$364k
NCI NIH HHS R21 CA233028NIGMS NIH HHS R01 GM107040
6 · The paper itself

Abstract

The Ccr4-Not complex functions as an effector of multiple signaling pathways that control gene transcription and mRNA turnover. Consequently, Ccr4-Not contributes to a diverse array of processes, which includes a significant role in cell metabolism. Yet a mechanistic understanding of how it contributes to metabolism is lacking. Herein, we provide evidence that Ccr4-Not activates nutrient signaling through the essential target of rapamycin complex 1 (TORC1) pathway. Ccr4-Not disruption reduces global TORC1 signaling, and it also upregulates expression of the cell wall integrity (CWI) pathway terminal kinase Mpk1. Although CWI signaling represses TORC1 signaling, we find that Ccr4-Not loss inhibits TORC1 independently of CWI activation. Instead, we demonstrate that Ccr4-Not promotes the function of the vacuole V-ATPase, which interacts with the Gtr1 GTPase-containing EGO complex to stimulate TORC1 in response to nutrient sufficiency. Bypassing the V-ATPase requirement in TORC1 activation using a constitutively active Gtr1 mutant fully restores TORC1 signaling in Ccr4-Not deficient cells. Transcriptome analysis and functional studies revealed that loss of the Ccr4 subunit activates the TORC1 repressed retrograde signaling pathway to upregulate mitochondrial activity. Blocking this mitochondrial upregulation in Ccr4-Not deficient cells further represses TORC1 signaling, and it causes synergistic deficiencies in mitochondrial-dependent metabolism. These data support a model whereby Ccr4-Not loss impairs V-ATPase dependent TORC1 activation that forces cells to enhance mitochondrial metabolism to sustain a minimal level of TORC1 signaling necessary for cell growth and proliferation. Therefore, Ccr4-Not plays an integral role in nutrient signaling and cell metabolism by promoting V-ATPase dependent TORC1 activation.

Indexed as

Cell Cycle ProteinsCell WallEndosomesGene Expression Regulation, FungalMitochondriaMitogen-Activated Protein KinasesMonomeric GTP-Binding ProteinsMultiprotein ComplexesRibonucleasesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSignal TransductionTranscription FactorsVacuolar Proton-Translocating ATPasesVacuolesCCR4 protein, S cerevisiaeCDC39 protein, S cerevisiaeCell Cycle ProteinsGtr1 protein, S cerevisiaeMEH1 protein, S cerevisiaeMitogen-Activated Protein KinasesMonomeric GTP-Binding ProteinsMultiprotein ComplexesRibonucleasesSaccharomyces cerevisiae ProteinsSLT2 protein, S cerevisiaeTORC1 protein complex, S cerevisiaeTranscription FactorsVacuolar Proton-Translocating ATPases

Identifiers

PMID33064727
PMCPMC7592917
OpenAlexW3093257997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.